Last reviewed · How we verify

NCT07057804

Lung and Diaphragm Ultrasound in Predicting Extubation and Weaning of Mechanically Ventilated Patients in Intensive Care Unit

Completed Last updated 10 July 2025
What this trial tests

trial testing Lung Ultrasound in Lung in 90 participants. Completed in 1 June 2025.

Timeline
1 June 2024
Primary endpoint
1 June 2025
1 June 2025

Quick facts

Lead sponsorKafrelsheikh University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 June 2024
Primary completion1 June 2025
Estimated completion1 June 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kafrelsheikh University

Who can join

18 and older, any sex, with Lung or Diaphragm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the role of lung ultrasound score (LUS), diaphragmatic excursion (DE), and diaphragmatic thickening fraction (DTF) as predictors of successful extubation in mechanically ventilated patients in the intensive care unit (ICU). It also compares these ultrasound-based parameters to traditional weaning criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lung Ultrasound

Trials testing the same drug.

Other recruiting trials for Lung

Currently open trials in the same condition.

Other Kafrelsheikh University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07057804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing